The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic inflammatory markers in neoadjuvant pembrolizumab therapy for triple-negative breast cancer: Prognostic insights and nomogram construction.
 
Filippo Giovanardi
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; MSD; Novartis; Roche; Seagen
 
Chiara Casartelli
No Relationships to Disclose
 
Roberto Di Cicilia
No Relationships to Disclose
 
Alessandra Bologna
No Relationships to Disclose
 
Elisa Gasparini
No Relationships to Disclose
 
Gabriella Moretti
No Relationships to Disclose
 
Claudia Degli Esposti
No Relationships to Disclose
 
Giancarlo Bisagni
No Relationships to Disclose
 
Carmine Pinto
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Incyte; Ipsen; Janssen; Merck Serono; MSD; Novartis; Roche; SERVIER
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Incyte; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; SERVIER
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Roche